Dados B3 › HYPE3 × FLRY3 · Português

HYPE3 × FLRY3

HYPE3

HYPERA S/A
Saúde

40 restated figures

FLRY3

FLEURY SA
Saúde

18 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicatorHYPE3FLRY3year
ROE9.7%11.9%2025
ROIC8.8%!11.6%2025
ROA4.8%4.5%2025
Gross margin59.0%26.6%2025
EBIT margin22.9%14.7%2025
Net margin15.5%7.2%2025
Net debt/EBITDA3.68x1.47x2025
Current ratio1.47x1.97x2025
Revenue growth (1y)3.4%7.9%2025
Revenue growth (5y CAGR)13.5%22.8%2025
Piotroski F-Score7/96/92025

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicatorHYPE3FLRY3year
P/E11.30x14.26x2025
P/B1.08x1.75x2025
EV/EBITDA10.17x5.58x2025
FCF yield13.1%18.6%2025

HYPE3 · FLRY3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:46 UTC. If this does not match /saude, you are reading a cached copy.

Home · Methodology · Transparency · Audit it